Avidity Biosciences Inc (RNA)
42.55
-1.10
(-2.52%)
USD |
NASDAQ |
Nov 21, 16:00
42.55
0.00 (0.00%)
After-Hours: 19:01
Avidity Biosciences Price to Book Value: 3.377 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.464 |
| November 19, 2024 | 3.432 |
| November 18, 2024 | 3.282 |
| November 15, 2024 | 3.347 |
| November 14, 2024 | 3.966 |
| November 13, 2024 | 4.166 |
| November 12, 2024 | 3.708 |
| November 11, 2024 | 3.740 |
| November 08, 2024 | 3.708 |
| November 07, 2024 | 3.770 |
| November 06, 2024 | 3.749 |
| November 05, 2024 | 3.578 |
| November 04, 2024 | 3.557 |
| November 01, 2024 | 3.323 |
| October 31, 2024 | 3.354 |
| October 30, 2024 | 3.43 |
| October 29, 2024 | 3.537 |
| October 28, 2024 | 3.628 |
| October 25, 2024 | 3.58 |
| October 24, 2024 | 3.583 |
| October 23, 2024 | 3.591 |
| October 22, 2024 | 3.747 |
| October 21, 2024 | 3.694 |
| October 18, 2024 | 3.99 |
| October 17, 2024 | 3.837 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.871 |
| October 15, 2024 | 3.693 |
| October 14, 2024 | 3.694 |
| October 11, 2024 | 3.686 |
| October 10, 2024 | 3.497 |
| October 09, 2024 | 3.619 |
| October 08, 2024 | 3.664 |
| October 07, 2024 | 3.476 |
| October 04, 2024 | 3.741 |
| October 03, 2024 | 3.721 |
| October 02, 2024 | 3.727 |
| October 01, 2024 | 3.837 |
| September 30, 2024 | 3.632 |
| September 27, 2024 | 4.098 |
| September 26, 2024 | 4.083 |
| September 25, 2024 | 4.449 |
| September 24, 2024 | 4.26 |
| September 23, 2024 | 4.212 |
| September 20, 2024 | 4.306 |
| September 19, 2024 | 4.420 |
| September 18, 2024 | 4.321 |
| September 17, 2024 | 4.085 |
| September 16, 2024 | 4.042 |
| September 13, 2024 | 4.038 |
| September 12, 2024 | 4.000 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6974
Minimum
Oct 27 2023
17.90
Maximum
Jun 22 2020
2.813
Average
2.802
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 8.645 |
| Vertex Pharmaceuticals Inc | 7.420 |
| Natera Inc | 25.46 |
| Entrada Therapeutics Inc | 1.601 |
| Alnylam Pharmaceuticals Inc | 984.20 |
Price to Book Value Related Metrics
| PS Ratio | 413.85 |
| Price | 42.55 |
| Earnings Yield | -6.79% |
| Market Cap | 5.077B |